Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,271
Out of 5,147 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $116.35 | +3.14% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $86.47 | +50.34% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $75.36 | +45.97% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.61 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $73.43 | -57.44% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $31.73 | +10.31% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $122.06 | +141.68% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $70.60 | +28.90% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $74.91 | -63.96% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $246.61 | -72.83% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $116.35
Upside: +3.14%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $86.47
Upside: +50.34%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $75.36
Upside: +45.97%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.61
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $73.43
Upside: -57.44%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $31.73
Upside: +10.31%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $122.06
Upside: +141.68%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $70.60
Upside: +28.90%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $74.91
Upside: -63.96%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $246.61
Upside: -72.83%